Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Clinical trial NCT01529645 · COMPLETED

Trial details

NCT number: NCT01529645
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pertussis Whooping Cough Tetanus Lockjaw Diphtheria

Start date: 2012-03-01
Primary completion: 2012-07-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.